Advertisement

Latest News

Taha Qazi, MD: Fenofibrate As First-Line Therapy in Primary Biliary Cholangitis

32 minutes ago

Qazi discusses a review of the use of fenofibrate as a first-line therapy in treatment-naive patients with PBC and its implications for biochemical response.

Managing Patients With High-Risk PDR and DME

1 hour ago

Ehsan Rahimy, MD, outlines strategies for managing cases of high-risk PDR and DME, exploring new therapies and synergistic combinations with anti-VEGF and steroids for longer-lasting responses.

LPCN 1148 Achieves Phase 2 Study Endpoints in Cirrhosis Management

1 hour ago

Topline results at week 52 show LPCN 1148 treatment met both the primary and hepatic encephalopathy endpoints in the management of cirrhosis.

Fenofibrates in the Treatment of Primary Biliary Cholangitis

1 hour ago

New data suggest adding fibrate therapy to frontline PBC treatment could result in earlier and higher rates of biochemical response.

Managing DME Patients Unresponsive to Anti-VEGF

1 hour ago

An expert retina specialist discusses challenges faced by DME patients showing suboptimal response to standard anti-VEGF treatment, emphasizing the need to reduce injection burden while preventing vision loss.

Advertisement
Advertisement